Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists

被引:111
作者
Kumar, K.
Daley, E.
Carruthers, D. M.
Situnayake, D.
Gordon, C.
Grindulis, K.
Buckley, C. D.
Khattak, F.
Raza, K. [1 ]
机构
[1] Univ Birmingham, Ctr Immune Regulat, MRC, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England
[2] Sandwell & West Birmingham Hosp NHS, Dept Rheumatol, Birmingham, W Midlands, England
[3] Univ Birmingham, MRC, Ctr Immune Regulat, Div Immun & Infect, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
rheumatoid arthritis; early arthritis; diagnosis; delay;
D O I
10.1093/rheumatology/kem130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To study the delay from the time of symptom onset to assessment by a Rheumatologist in patients with rheumatoid arthritis (RA) and to determine the contributions of patient and physician dependent factors to this delay. Methods. Data were collected from 169 consecutive patients with RA at the time of assessment by Rheumatologists working in hospitals serving an inner city population in Birmingham, UK. Dates were recorded for: (i) onset of inflammatory joint symptoms; (ii) initial assessment in primary care; and (iii) referral from primary to secondary care. (iv) initial assessment by a rheumatologist in secondary care. Results. The median delay from the onset of symptoms to a patient being assessed in secondary care was 23 weeks (IQR 12-54 weeks). The median delay before the patient was assessed in primary care was 12 weeks (IQR 4-28 weeks). For 96 patients (57%) more than half of the overall delay in assessment in secondary care was accounted for by a delay in assessment in primary care. Conclusions. Patient dependent factors, leading to a delay in consulting primary care physicians, are the principal reasons for the delay in patients with RA being seen by Rheumatologists in our population. A considerable body of evidence demonstrates that the earlier that therapy is introduced the better the clinical outcome. Consequently it is important to understand why some patients with RA delay in seeking medical advice, in order to allow effective interventions to reduce this delay.
引用
收藏
页码:1438 / 1440
页数:3
相关论文
共 14 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis - Results from the Norfolk Arthritis Register study, a large inception cohort [J].
Bukhari, M ;
Lunt, M ;
Harrison, BJ ;
Scott, DGI ;
Symmons, DPM ;
Silman, AJ .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :906-912
[3]   EARLY RHEUMATOID-ARTHRITIS - TIME TO AIM FOR REMISSION [J].
EMERY, P ;
SALMON, M .
ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (12) :944-947
[4]  
Hernandez-Carcia C, 2000, J RHEUMATOL, V27, P2323
[5]   Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice [J].
Irvine, S ;
Munro, R ;
Porter, D .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (08) :510-513
[6]   IGM, IGG AND IGA RHEUMATOID FACTORS (ANTIGLOBULINS) IN EARLY RHEUMATOID-ARTHRITIS AND THEIR PRODUCTION OF ARTICULAR INDEX OVER ONE YEAR [J].
MARCH, RE ;
KIRWAN, JR ;
REEBACK, JS ;
HOLBOROW, EJ .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1987, 16 (06) :407-411
[7]   Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis [J].
Möttönen, T ;
Hannonen, P ;
Korpela, M ;
Nissilä, M ;
Kautiainen, H ;
Ilonen, J ;
Laasonen, L ;
Kaipiainen-Seppänen, O ;
Franzen, P ;
Helve, T ;
Koski, J ;
Gripenberg-Gahmberg, M ;
Myllykangas-Luosujärvi, R ;
Leirisalo-Repo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :894-898
[8]   Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis [J].
Nell, VPK ;
Machold, KP ;
Eberl, G ;
Stamm, TA ;
Uffmann, M ;
Smolen, JS .
RHEUMATOLOGY, 2004, 43 (07) :906-914
[9]   Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis [J].
Nell, VPK ;
Machold, KP ;
Stamm, TA ;
Eberl, G ;
Heinzl, H ;
Uffmann, M ;
Smolen, JS ;
Steiner, G .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) :1731-1736
[10]   Women with early rheumatoid arthritis are referred later than men [J].
Palm, O ;
Purinszky, E .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1227-1228